Tumor necrosis factor (TNF-α) and interleukin 6 (IL-6) plasma levels in patients with acute myocardial infarction;Steżenia czynnika martwicy nowotworów (TNF-α) i interleukiny 6 (IL-6) w surowicy chorych na świeży zawał mieśnia serca

Polskie Archiwum Medycyny Wewnetrznej

Volumn 101, Issue 3, 1999, Pages 197-203

  Halawa, Bogumil ^a   Salomon, Piotr ^b   Jołda Mydłowska, Beata ^b   Zyśko, Dorota ^b  

^a Wroclaw Medical University Katedra i Klinika Kardiologii   (Poland)

^b NONE

Author keywords

Interleukin 6; Myocardial infarction; Tumor necrosis factor

Indexed keywords

CREATINE KINASE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; CREATINE KINASE; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033084778     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bozkurt B., Kribbs S.B., Clubb F.J.: Patophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation, 1998, 97, 1382.
2. Neumann F.-J., Gawaz M., Richardt G., Holzapfel H., Jochum M., Schoming: Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation, 1995, 92, 748.
3. Nakano M., Knowlton A.A., Dibbs Z., Mann D.L.: Tumor necrosis factor-α confers resistance to hypoxic injurry in the adult mammalian cardiac myocyte. Circulation, 1998, 97, 1392.
4. Maury C.P.J., Teppo A.-M.: Circulating tumor necrosis factor-α (cachectin) in myocardial infarction. J. Intern. Med., 1989, 225, 333.
5. Torre-Amione G., Kapadia S., Lee J., Bies R.D., Lebovitz R., Mann D.L.: Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation, 1995, 92, 1487.
6. Kowalczyk D.: Monocyty i makrofagi. I. Ogólna charakterystyka. Przeg. Lek., 1991, 48, 705.
7. Vanderheyden M., Kersschot E., Paulus W.J.: Proinflamatory cytokines and endothelium-dependent vasodilatation in the forearm. Eur. Heart J., 1998, 19, 747.
8. Hasper D., Hummel M., Klebert F.X., Reindlt I., Volkt H.D.: Systemic inflammation in patients with heart failure. Eur. Heart J., 1998, 19, 761.
9. Munger M.A., Johnson B., Amber I.J., Callahan K.S, Gilber: E.M.: Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathie. Am. J. Cardiol., 1996, 77, 723.
10. Ono K., Matsumori A., Shioi T., Furukawa Y., Sasayama S.: Cytokine gene expresion after myocardial infarction in rat hearts, possible implication in left ventricular remodeling. Circulation, 1998, 98, 149.